| __timestamp | Bristol-Myers Squibb Company | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 14683100000 |
| Thursday, January 1, 2015 | 12651000000 | 14921500000 |
| Friday, January 1, 2016 | 14481000000 | 15567200000 |
| Sunday, January 1, 2017 | 14710000000 | 16801100000 |
| Monday, January 1, 2018 | 16014000000 | 16811600000 |
| Tuesday, January 1, 2019 | 18067000000 | 17598300000 |
| Wednesday, January 1, 2020 | 30745000000 | 19056500000 |
| Friday, January 1, 2021 | 36445000000 | 21005600000 |
| Saturday, January 1, 2022 | 36022000000 | 21911600000 |
| Sunday, January 1, 2023 | 34313000000 | 27041900000 |
| Monday, January 1, 2024 | 36351000000 | 36624400001 |
Cracking the code
In the ever-evolving pharmaceutical industry, Eli Lilly and Bristol-Myers Squibb have consistently demonstrated their prowess. From 2014 to 2023, these two titans have shown remarkable growth in gross profit, reflecting their strategic innovations and market adaptability.
Eli Lilly's gross profit surged by approximately 84% over the decade, peaking in 2023. This growth underscores their successful product launches and expansion into emerging markets.
Bristol-Myers Squibb, on the other hand, experienced a dramatic 187% increase in gross profit, with a notable spike in 2020. This leap can be attributed to their strategic acquisitions and robust pipeline of new therapies.
Both companies have navigated challenges and capitalized on opportunities, setting benchmarks in the pharmaceutical sector. Their financial trajectories offer valuable insights into the industry's future.
Gross Profit Analysis: Comparing Eli Lilly and Company and AstraZeneca PLC
Gross Profit Comparison: Eli Lilly and Company and Biogen Inc. Trends
Who Generates Higher Gross Profit? Eli Lilly and Company or Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: Eli Lilly and Company vs Bio-Techne Corporation
Novo Nordisk A/S vs Bristol-Myers Squibb Company: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Genmab A/S
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc
Bristol-Myers Squibb Company and Perrigo Company plc: A Detailed Gross Profit Analysis